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Abstract
We previously reported that at 1-and-4 weeks of sobriety, those who relapsed after treatment
demonstrated significantly smaller total frontal cortical volume than individuals who maintained
abstinence for at least 12 months post treatment. The segmentation method employed did not
permit examination of frontal subregions that serve as nodes of the executive, salience and
emotional regulation networks; structural abnormalities in these circuits are associated with
relapse in those seeking treatment for alcohol use disorders (AUD). The primary goal of this study
was to determine if frontal cortical subregion volume recovery during early abstinence is
associated with long-term abstinence from alcohol. We compared bilateral components of the
dorsal prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex and insula volumes, at 1 and
4 weeks of abstinence, between individuals who resumed drinking within 12 months of treatment
(Relapsers) those who showed sustained abstinence over 12 months following treatment
(Abstainers) and healthy Controls. At 1 and 4 weeks of sobriety, Relapsers demonstrated
significantly smaller volumes than Controls in the 15 of 20 regions of interest, while Abstainers
only had smaller volumes than Controls in 5 of 20 regions. In Relapsers, increasing volumes over
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1 month in multiple frontal subregions and the insula were associated with longer duration of
abstinence after treatment. The persistent bilateral frontal and insula volume deficits in Relapsers
over 4 weeks from last alcohol use may have implications for neurostimulation methods targeting
anterior frontal/insula regions, and represent an endophenotype that differentiates those who
respond more favorably to available psychosocial and pharmacological interventions.
Keywords
alcohol use disorder; brain volumes; relapse; magnetic resonance imaging; neurostimulation
INTRODUCTION
Approximately 60% of individuals with an alcohol use disorder (AUD) will relapse to
hazardous alcohol consumption within 6 months of treatment with currently available
psychosocial and pharmacological interventions (Witkiewitz, 2011). Non-invasive
neurostimulation techniques, such as repetitive transcranial magnetic stimulation (rTMS),
are increasingly being evaluated as novel treatments for individuals with AUD and
substance use disorders (SUD) (Dunlop, Hanlon, & Downar, 2017; Salling & Martinez,
2016). Studies investigating the neurobiological effects and/or clinical efficacy of rTMS in
AUD and SUD have most frequently targeted the dorsolateral prefrontal cortex (DLPFC),
dorsomedial prefrontal cortex, ventromedial prefrontal cortex, and insula (Bellamoli et al.,
2014; Salling & Martinez, 2016), with the DLPFC and ventromedial prefrontal cortex as the
most common rTMS targets in AUD. Magnetic resonance (MR) imaging studies of AUD
have demonstrated that those who relapse after treatment, compared to individuals who
maintain extended abstinence, exhibit smaller volumes in dorsolateral, dorsomedial,
ventromedial and orbitofrontal prefrontal cortical regions during the first month of
abstinence (Beck et al., 2012; Cardenas et al., 2011; Durazzo et al., 2011; Rando et al.,
2011). The collective MR-based morphometric studies investigating biomarkers for relapse
in AUD indicate the macrostructural integrity of anterior frontal regions that are nodes of the
executive, salience, reward and emotional regulation networks (Moorman, 2018; Seeley et
al., 2007; Williams, 2016) is related to treatment outcome (Seo & Sinha, 2014, 2015).
Therefore, the neurobiological effects of rTMS may be influenced by the macrostructural
integrity and/or level of atrophy of brain tissue that is the target of stimulation (Stokes et al.,
2007). We previously employed a different MR image segmentation method (Durazzo,
Mon, Gazdzinski, & Meyerhoff, 2016) in the same cohort used for the current analysis and
found that individuals who relapsed within 12 months after treatment, compared to those
who had sustained abstinence for at least 12 months, showed significantly smaller bilateral
total frontal gray matter (GM) volumes at approximately 1-week of sobriety. Over the
ensuing 3-weeks, both abstainers and relapsers demonstrated significant and equivalent rates
of change in total frontal GM volume, a macroscopic indicator of adaptive neuroplasticity
(Buhler & Mann, 2011; Durazzo, Mon, Gazdzinski, Yeh, & Meyerhoff, 2015); however,
only relapsers continued to exhibit smaller total bilateral frontal GM volumes than controls
at 4-weeks of monitored sobriety. Given that previous clinical trials evaluating the efficacy
of rTMS were logically initiated during the early phase of treatment and targeted anterior
frontal lobe subregions, regional differences in volume recovery during this early phase may
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influence rTMS treatment response. To date, no study has specifically investigated volume
changes of anterior frontal cortical regions of future abstainers and relapsers, during the
early phase of recovery, that also may serve as rTMS cortical targets.
Our primary goal was to determine if volume changes in frontal cortical and anterior
cingulate subregions and the insula of alcohol dependent participants during early abstinence
are associated with treatment outcome. Specifically, we compared bilateral anterior
cingulate, orbitofrontal, and dorsolateral subregions, as well as bilateral insula and
precentral gyrus volumes during early recovery between those who resumed alcohol
consumption within 12 months of treatment (Relapsers), those who successfully maintained
abstinence over 12 months after treatment (Abstainers) and healthy controls (Controls). This
study extends our previous research by investigating functionally distinct subregions of the
frontal cortex during early abstinence from alcohol. We hypothesized that: 1) Compared to
Controls, both Abstainers and Relapsers demonstrate smaller regional volumes at
approximately 1 week (assessment point 1; AP1) and 4 weeks (assessment point 2; AP2) of
abstinence; 2) Relapsers show smaller volumes than Abstainers in all regions at AP1 and
AP2; 3) Relapsers show less volume recovery in all regions than Abstainers over
approximately 4 weeks of sustained abstinence; and 4) In Relapsers, greater regional volume
recovery over 4 weeks is related to longer duration of abstinence following treatment.
MATERIALS AND METHODS
Participants
Individuals seeking treatment for AUD (n = 119) were recruited from the San Francisco VA
Medical Center (SFVAMC) Substance Abuse Day Hospital and the San Francisco Kaiser
Permanente Chemical Dependence Recovery outpatient treatment clinics [for additional
information on the treatment program characteristics see (Durazzo, Gazdzinski, Yeh, &
Meyerhoff, 2008)]. The predominantly male Veteran treatment-seeking patients were
between 28 and 71 years of age and met DSM-IV criteria for alcohol dependence. All
alcohol dependent individuals were actively in treatment at the time of assessment, and
treatment duration typically ranged from 14–35 days (median of 21 days). Thirty-three non-
smoking, light drinking controls (Controls) were recruited from the local community and
screened for biomedical or psychiatric conditions known or suspected to influence brain
neurobiology. All participants provided written informed consent prior to study. Study
procedures were approved by the University of California San Francisco and the SFVAMC
and were in accordance with the ethical standards of the Declaration of Helsinki.
Inclusion/exclusion criteria: Primary inclusion criteria for the alcohol dependent
participants were fluency in English, DSM-IV diagnosis of alcohol dependence/abuse at
baseline (all met criteria for alcohol dependence), consumption of greater than 150 standard
alcohol-containing drinks (i.e., 13.6 grams of pure ethanol) per month for at least 8 years
prior to enrollment for males, and greater than 80 drinks per month for at least 6 years prior
to enrollment for females. See Table 1 for group demographic data. Alcohol dependent
individuals were excluded for any history of the following: dependence on any substance
other than alcohol or nicotine in the 5 years immediately prior to enrollment, any
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intravenous drug use in the 5 years prior to baseline study, opioid agonist therapy, HIV/
AIDS, cerebrovascular accident, cerebral aneurysm, arteriovenous malformations,
myocardial infarction, medically uncontrolled chronic hypertension (systolic > 180 and/or
diastolic > 120 mmHg), type-I diabetes, chronic obstructive pulmonary disease, non-alcohol
related seizures, significant exposure to established neurotoxins, intrinsic cerebral masses,
demyelinating and neurodegenerative diseases, Wernicke-Korsakoff syndrome, delirium,
penetrating head injury, and closed head injury resulting in loss of consciousness > 10
minutes. Psychiatric exclusion criteria were history of schizophrenia-spectrum disorders,
bipolar disorder, cyclothymia, PTSD, obsessive-compulsive disorder and panic disorder.
Hepatitis C, type-2 diabetes, hypertension, unipolar mood disorders (i.e., major depression,
substance-induced mood disorder) were allowed in the alcohol dependent group, given their
high prevalence in AUD (Grant et al., 2015; Mertens, Weisner, Ray, Fireman, & Walsh,
2005). Participants were breathalyzed and urine-tested for illicit substances before all
assessments. Additionally, the treatment programs regularly tested participants for alcohol
and substance use. No participant tested positive for alcohol or substances during treatment
or at any AP.
Seventy-eight alcohol dependent participants (24 Abstainers; 54 Relapsers) completed a
magnetic resonance imaging (MRI) study 7 ± 4 days after consumption of their last alcohol
drink (AP1); eleven individuals relapsed between AP1 and AP2 and had no AP2 scan. One
hundred four alcohol dependent participants (39 Abstainers; 65 Relapsers) completed an
MRI after approximately 33 ± 9 days of abstinence (AP2). Sixty-three participants were
studied at both AP1 and AP2, but four were excluded at AP2 because of inferior data
quality. Forty-one participants were enrolled and first studied at AP2, because they
completed acute detoxification at another SFVAMC or Kaiser Permanente sponsored
program, precluding their participation at AP1. Control participants completed a single MR
study and clinical assessment.
Definition of Abstainers and Relapsers and follow-up procedures: Participants
were followed for 12 months following AP2. Initial follow-up 1 (in person, telephone and/or
collateral source interview, and/or medical record review) took place 5–7 months after AP2.
Seventy-six of the 119 alcohol dependent participants originally studied at AP2 were
revaluated approximately 7 months later with all MR scans, psychiatric and behavioral
measures administered at AP1 as well as the Time Line Follow-Back (L. C. Sobell et al.,
1988; L. Sobell, Sobell, Maisto, & Cooper, 1985) to specifically assess alcohol consumption
patterns during relapse. For the remaining 43 participants, follow-up 1 assessment involved
brief in-person and/or telephone contact (n = 25), review of available medical records (n =
17), and/or telephone interview of collateral sources (i.e., family or friends; n = 1), where
only relapse status (i.e., any alcohol consumption) and date of relapse onset (if known) was
obtained. Abstainers: participants were designated as Abstainers if they met all the following
criteria: a) self-reported no alcohol consumption between AP1-AP2 and long-term follow-
up; b) there was no report of alcohol consumption between baseline and follow-ups in
available medical records; and c) available laboratory indicators of alcohol consumption
(gamma glutamyltransferase; GGT) were within normal limits at follow-up. For follow-up 2,
all Abstainers were contacted (in-person or via telephone) again approximately 5–7 months
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after the follow-up 1 to determine if they maintained continuous sobriety over the 12-month
observation period. Relapsers: participants were designated as Relapsers if they met any of
the following criteria: a) self-report of any alcohol consumption after AP1 or AP2 within 12
months via in-person or telephone interview; b) alcohol consumption or relapse was
indicated in available medical records; c) report of participant alcohol use provided by a
relative or close friend via telephone contact. In our previous studies, any level of alcohol
consumption following treatment was associated with compromised psychosocial
functioning (Durazzo et al., 2008). See Figure 1 for summary of participant assessment
timeline.
Clinical Measures
Participants completed the Clinical Interview for DSM-IV Axis I Disorders, Version 2.0
(SCID-I/P) and semi-structured interviews for lifetime alcohol consumption (Lifetime
Drinking History) and substance use (in-house questionnaire assessing substance type, and
quantity and frequency of use). From the Lifetime Drinking History, average number of
alcoholic drinks/month over 1 year prior to enrollment, and average number of drinks/month
over lifetime were calculated. At AP1 and AP2, participants also completed standardized
questionnaires assessing depressive (Beck Depression Inventory, BDI) and anxiety
symptomatology (State-Trait Anxiety Inventory, Trait form Y-2, STAI), as well as nicotine
dependence via the Fagerstrom Tolerance Test for Nicotine Dependence (FTND). See
(Pennington et al., 2013) for corresponding references for the above measures.
MR Data Acquisition and Processing
Structural images were acquired on a 1.5 Tesla MR system (Vision, Siemens Medical
Systems, Iselin NJ) with a T1-weighted Magnetization Prepared Rapid Acquisition Gradient
Echo sequence (MPRAGE; 1 × 1 mm2 in-plane resolution, 1.5 mm contiguous slabs)
oriented orthogonal to the long axis of the hippocampus [see (Mon et al., 2013) for specific
imaging parameters]. The publicly available FreeSurfer (v4.5) volumetric segmentation and
cortical surface reconstruction methods were used to obtain cross-sectional (Fischl et al.,
2004) and longitudinal (Reuter, Schmansky, Rosas, & Fischl, 2012) measures of regional
cortical volumes (mm3) from T1-weighted MPRAGE images. First, cross-sectional scans of
all participants were processed followed by rigorous quality control and manual editing, if
necessary (Durazzo et al., 2014). An unbiased template of each participant was then created
from the cumulative cross-sectional data. Longitudinal processing for alcohol dependent
participants was performed on the cross-sectional data with the template for each participant
that generated 34 anatomical regions of interest per cortical hemisphere. Average cortical
volume was obtained for all 34 bilateral cortical regions of interest (ROI), but analyses were
confined to frontal and anterior cingulate subregions, and insula (see Table 2). Volumes
from the lateral orbitofrontal and pars orbitalis for each hemisphere were summed because
these regions are often considered to constitute the lateral orbitofrontal cortex [see (Fettes,
Schulze, & Downar, 2017) and references therein]. The precentral gyri was included
because the treatment level of rTMS is typically based on the motor threshold (magnitude
required by a single TMS pulse to consistently elicit motor activity) of select contralateral
upper or lower extremity muscles (George, 2007). All cortical ROI volumes that comprise
the frontal neocortex (superior frontal gyri, rostral and caudal middle frontal gyri, frontal
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pole, precentral gyri, medial and lateral orbitofrontal cortex, and pars triagularis, opercularis
and orbitalis), were summed for each hemisphere to form total left and right frontal cortex
volumes. Please see Durazzo et al., 2011 for a representative figure of the ROIs used in this
study.
Data Analyses
Demographic and clinical data: Comparisons of demographic and clinical data
between Controls, Abstainers and Relapsers were conducted with univariate analysis of
variance and Fishers Exact Test, where indicated. There were no significant differences in
demographic or clinical variables between the alcohol dependent cohorts at AP1 and AP2,
except for lower BDI and STAI scores at AP2; therefore, values for the larger AP2 sample
are reported in all tables.
Cross-sectional regional brain volumetric comparisons between Controls,
Abstainers and Relapsers: Group comparisons on regional GM volumes at AP1 and
AP2 were conducted with generalized linear modeling and follow-up pairwise t-tests.
Controls were younger and had more years of education than Abstainers and Relapsers (see
Table 1). Therefore, age, education and intracranial volume (ICV) were used as covariates in
univariate models and pairwise t-tests between Controls and the alcohol dependent groups.
Average number of drinks/month over lifetime, years of education and frequency of
psychiatric comorbidities (primarily unipolar mood disorders) were significantly higher in
Relapsers than Abstainers (see Table 1); these variables, age and ICV were used as
covariates in all pairwise t-tests for Abstainers and Relapsers. Effect sizes for pairwise t-
tests of group means were calculated with Cohen’s d (Cohen, 1977). Although we specified
a priori predictions for frontal GM differences between Abstainers and Relapsers, statistical
significance levels (p < .05) for all pairwise t-tests at AP1 and AP2 were corrected for
multiple comparisons accounting for the 18 ROIs (left and right total frontal cortical
volumes were treated as separate summary measures) and the average intercorrelations
among ROIs for all groups combined (r = 0.77). This modified Bonferroni method (Sankoh,
Huque, & Dubey, 1997) yielded an adjusted significance level of p ≤ .026 for pairwise t-
tests. The same regional volume values for Controls were used for AP1 and AP2
comparisons with Abstainers and Relapsers; this is justified as we previously observed no
significant regional volumes changes in this Control cohort over approximately 6 months
(Durazzo et al., 2015).
Longitudinal regional brain volumetric comparisons between Abstainers and
Relapsers: Longitudinal ROI volume changes in Abstainers and Relapsers over
approximately 1 month of abstinence were assessed with linear mixed modeling. In this
analysis, the focus was on the group (Abstainers vs. Relapsers) x days abstinent interaction
and the main effect for days abstinent (time). Main effects for days abstinent were followed-
up with simple effects tests for Abstainers and Relapsers. Random intercepts were modeled
for all participants. Average number of drinks/month over lifetime, age, years of education,
frequency of comorbid psychiatric conditions, and ICV were employed as covariates in
these analyses. Interactions, main and simple effects for all ROIs were considered
statistically significant at p < .05.
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Associations between regional brain volume changes and duration of post-
treatment abstinence in Relapsers: Associations between change in regional brain
volumes and duration of abstinence after treatment in Relapsers were assessed for Relapsers
via linear mixed modeling. The duration of post-treatment abstinence served as the
dependent measure, with age, lifetime average drinks/month, ICV and ROI volume (e.g., left
lateral OFC) as predictors. These exploratory associations were considered statistically
significant at p < .05.
RESULTS
Group demographics and clinical measures
Controls were younger, had more education, and demonstrated lower BDI and STAI scores
than Abstainers and Relapsers (all p < .05). Abstainers and Relapsers were equivalent on
age, BDI and STAI scores, duration of abstinence at AP1 and AP2, cigarette consumption
measures, and frequency of the following: anti-relapse/craving medication use,
antidepressant use, cigarette smokers, history of substance use disorders and comorbid
medical conditions. The most common medical conditions among the alcohol dependent
group were hypertension (n = 28) and hepatitis C positivity (n = 15), and Abstainers and
Relapsers were equivalent on the frequency of these conditions. Abstainers had a higher
level of education, lower lifetime alcohol consumption and a lower frequency of psychiatric
comorbidities than Relapsers (all p < .05). The three groups were equivalent on ICV and
percent of male and Caucasian participants (See Table 1). .
Volume comparisons of Controls, Abstainers and Relapsers at AP1 (1 week of abstinence)
As seen in Table 2, Relapsers showed significantly smaller volumes than Controls in
bilateral precentral gyrus, insula and total frontal cortex, as well as in multiple subregions of
anterior cingulate (ACC), orbitofrontal (OFC), dorsal prefrontal (DPFC) cortical subregions
(all p ≤ .026); the magnitude of these differences were moderate to strong. Abstainers had
significantly smaller volumes than Controls in the left rostral ACC, right medial OFC,
bilateral insula and left total frontal cortex, with correspondingly moderate effect sizes (all p
≤ .026). Relapsers exhibited smaller volumes than Abstainers in the left lateral OFC, right
superior frontal gyrus, bilateral precentral gyri and bilateral total frontal cortex (all p ≤ .026),
with moderate to strong effect sizes. Greater age was inversely related to volumes in all
regions (p < .01) except bilateral ACC subregions and bilateral insula. In comparisons
between Abstainers and Relapsers, average number of drinks/month over lifetime, years of
education, and frequency of psychiatric comorbidities were not significant predictors of
volume for any ROI.
Volume changes for Abstainers and Relapsers over AP1-AP2 Interval
Main effects for group (Abstainers vs. Relapsers) were observed for the left rostral ACC,
left lateral OFC, right rostral middle frontal gyrus, bilateral precentral gyrus and bilateral
total frontal cortex; in all these main effects, Abstainers had larger volumes than Relapsers
across AP1-AP2 (see Fig. 2 for representative pattern for these regions). Main effects for
days abstinent (time) were significant for all regions except the ACC subregions, right
caudal middle frontal gyrus, and right precentral gyrus. Simple effects tests indicated that
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the main effects for days abstinent for the bilateral lateral OFC, bilateral rostral middle
frontal gyrus, left precentral gyrus, and bilateral insula were driven by significant volume
recovery in Relapsers. (see Fig. 3 for representative pattern for these regions). The main
effects for days abstinent for the bilateral superior frontal gyrus was driven by statistically
significant volume recovery in Abstainers. Relapsers volume change for the superior frontal
gyrus over the AP1-AP2 interval was not significant, but they showed a similar percent
change as Abstainers for this region. Greater age was inversely related to volume increases
in all regions (p < .01) except bilateral ACC subregions and bilateral insula. Average
number of drinks/month over lifetime, years of education, and frequency of psychiatric
comorbidities were not significant predictors of volume change for any ROI (see Table 3).
Volume comparisons of Controls, Abstainers and Relapsers at AP2 (4 weeks of
abstinence)
At approximately 4 weeks of abstinence, Relapsers continued to demonstrate significantly
smaller volumes than Controls in the bilateral precentral gyrus, insula and total frontal
cortex, left rostral and right caudal ACC, as well as in multiple subregions of the OFC and
DPFC (all p ≤ .026); the magnitude of these differences were moderate to strong. Abstainers
had significantly smaller volumes than Controls in the left rostral ACC, and bilateral insula
(all p ≤ .026), with moderate effect sizes. Relapsers showed smaller volumes than
Abstainers in the right caudal ACC, and bilateral superior frontal cortex, precentral gyrus
and total frontal cortex (all p ≤ .026), with moderate sizes for these differences. Greater age
was associated with smaller volumes in all regions (p < .01) except bilateral ACC
subregions and bilateral insula. In comparisons between Abstainers and Relapsers, average
number of drinks/month over lifetime, years of education, and frequency of psychiatric
comorbidities were not significant predictors of volume for any ROI (see Table 4).
Associations between regional brain volume changes and duration of post-treatment
abstinence in Relapsers
Relapsers maintained sobriety for 137 ± 80 days after treatment. In Relapsers, increasing
volumes over the AP1-AP2 interval in the following regions were positively related to
longer duration of sobriety after treatment: left lateral OFC [β = .022, standard error of the
estimate (SE) = .006; F(1, 103) = 12.3, p = .001], right lateral OFC [β = .023, SE = .007;
F(1, 103) = 16.5, p < .001], right precentral gyrus [β = .012, SE = .004; F(1, 103) = 6.5, p = .
012], left insula [β = .036, SE = .012; F(1, 103) = 9.3, p = .003], right insula [β = .035, SE
= .012; F(1, 103) = 9.1, p = .003], left caudal middle frontal [β = .015, SE = .005; F(1, 103)
= 7.3, p = .005], total left frontal [β = .023, SE = .012; F(1, 101) = 6.8, p = .010], and total
right frontal [β = .020, SE = .010; F(1, 101) = 6.2, p = .015].
DISCUSSION
The primary findings from this predominately Caucasian, male, Veteran cohort were: 1) At
approximately 1 week of sobriety (AP1), Relapsers exhibited smaller volumes than Controls
in 15 of 20 ROIs, while Abstainers had smaller volumes than Controls in only 5 of 20 ROIs
investigated. Relapsers showed smaller volumes than Abstainers in the left lateral OFC,
right superior frontal gyrus, and bilateral precentral gyrus and total frontal cortex. 2) Over
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the AP1-AP2 interval, Abstainers demonstrated significant volume recovery in the left
medial OFC, bilateral superior frontal gyri and total frontal cortex. Relapsers showed
significant volume increases in the left medial OFC, left insula and bilateral lateral OFC,
rostral middle frontal gyri and total frontal cortex. 3) At approximately 4 weeks of sobriety
(AP2), Relapsers continued to demonstrate smaller volumes than Controls in the same 15 of
20 regions apparent at AP1. Abstainers continued to show smaller volumes than Controls
only in the left rostral ACC and bilateral insula. Relapsers exhibited smaller volumes than
Abstainers in the right caudal ACC, bilateral superior frontal gyri, and bilateral precentral
gyri and total frontal cortex at AP2; importantly, these volume differences were not
explained by demographic, clinical or alcohol consumption variables. 4) In Relapsers,
greater volume increases in multiple frontal cortical subregions and the insula over the AP1-
AP2 interval were related to longer duration of abstinence after treatment.
Although our longitudinal analyses did not reveal a significant group x days abstinent
interaction for any ROI, Abstainers and Relapsers did exhibit a different pattern of recovery
for most ROIs over the AP1-AP2 interval. Relapsers had significant volume increases in 10
ROIs, whereas Abstainers showed recovery in only 6 ROIs. The left medial OFC, left caudal
middle frontal cortex and bilateral total frontal cortex were the only ROIs where both
Abstainers and Relapsers showed significant volume increases over the AP1-AP2 interval.
Despite the significant volume increases in Relapsers for multiple ROIs over the AP1-AP2
interval, at AP2, they continued to demonstrate significantly smaller volumes than Controls
and Abstainers in the same ROIs as AP1. At AP2, Abstainers only continued to show
smaller volumes than Controls in the left rostral ACC and bilateral insula. At both AP1 and
AP2, in all ROIs where Abstainers had smaller volumes than Controls, Relapsers also
demonstrated smaller volumes than Controls.
The structural integrity of components of circuits subserving fundamental aspects of
executive functions, assignment of external and internal stimulus salience, and emotional/
mood regulation (Seeley et al., 2007; Volkow & Baler, 2014; Williams, 2016), as assessed
by volumetric voxel-wise and ROI analyses, has been repeatedly shown to relate to
treatment outcome [see (Durazzo & Meyerhoff, 2017; D. Seo & Sinha, 2015) and references
therein]. Correspondingly, dysfunction in executive skills, impulse control, and assignment
of stimulus salience and mood disorders are associated with relapse in AUD (Bates,
Buckman, & Nguyen, 2013; Durazzo & Meyerhoff, 2017; D. Seo & Sinha, 2014; S. Seo et
al., 2015). Relapsers demonstrated significant volume deficits, throughout the initial month
of sobriety, in multiple regions that are cortical nodes in the above circuits. Alternately, at
both AP1 and AP2, Abstainers showed smaller volumes than Controls in only a few of these
cortical nodes. The results from AP1 cross-sectional comparisons indicate that Relapsers
entered treatment with markedly greater structural injury than Abstainers in multiple
subregions of the ACC, OFC, DPFC as well as across the left and right total frontal cortex.
The significant volume increases in 10 ROIs in Relapsers suggest adaptive plasticity in those
regions, despite continuing to exhibit significant volume deficits at AP2. The exact
processes and mechanisms contributing to the disparate cross-sectional and longitudinal
volumetric results for Abstainers and Relapsers are unclear. The findings for Abstainers and
Relapsers were not attributable to age, level of lifetime alcohol consumption, education,
cigarette smokers, use of anti-craving medications or psychiatric comorbidities. However,
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the cross-sectional and longitudinal results for Abstainers and Relapsers may be related to
potential differences in premorbid factors [e.g., polymorphisms in neurotrophic factors,
genetic and/or other vulnerability for hazardous alcohol consumption (Mon et al., 2013;
Tessner & Hill, 2010)], or comorbid factors (e.g., diet/nutrition, exercise, social
environment, subclinical pulmonary, hepatic, cardiac, or cerebrovascular dysfunction) not
specifically assessed in this report, and clearly warrant consideration in future studies.
The findings may have implications for rTMS and potentially other non-invasive
neurostimulation methods. The safe and effective application of rTMS-induced brain
stimulation necessitates consistent and accurate regulation of the magnitude of stimulation
of the target tissue. To titrate the magnitude of stimulation for the individual, rTMS output is
typically adjusted to an observable physiological measure of cortical activity, such as
evoked motor response of the thumb following excitation of the contralateral primary motor
cortex (George, 2007). For rTMS, the distance from the stimulation coil (placed adjacent to
scalp) to the cortex influences the level of stimulation of the underlying tissue (Stokes et al.,
2005). Adjustment of stimulation magnitude to the target site based on the distance of the
coil from the primary motor cortex (precentral gyrus) to the target site are recommended for
optimizing rTMS treatment (Stokes et al., 2007). The left dorsolateral prefrontal cortex was
a common stimulation target of previous rTMS studies in AUD. At both AP1 and AP2,
Relapsers and Abstainers showed disparate levels of volume loss of the left precentral gyrus
and DPFC. Abstainers had numerically larger left precentral gyrus volumes at both AP1 and
AP2, and averaged 4.6 percent smaller DPFC volume over the AP1-AP2 interval than
Controls; Relapsers averaged 5.5 percent smaller left precentral gyrus volumes and 9.4
percent smaller DPFC volume than Controls over the AP1-AP2 interval. Considering the
level of atrophy in Abstainers and Relapsers in the foregoing regions will influence length
from the skull to the cortical surface, distance adjusted stimulation output for a dorsolateral
anterior frontal target may have been required for proper calibration of rTMS output
intensity in this sample.
In Relapsers, greater increases in the left caudal middle frontal gyrus, right precentral gyrus
and bilateral insula, lateral OFC and total frontal cortex were related to longer duration of
abstinence after treatment. Over the AP1-AP2 interval, Relapsers showed significant volume
increases in most of these regions with the greatest increases in the bilateral insula. The
lateral OFC is implicated in switching between habitual behavior and goal-directed behavior
following evaluation consequences as well as reward identification and acquisition
(Moorman, 2018; Rolls & Grabenhorst, 2008) and the collective components of the insula
are key neural substrates involved in modulating drive and craving-related aspects of reward
processing (Paulus, 2007). A variety of neurobiological abnormalities, reflecting adverse
neuroplastic and functional changes of the insula, lateral OFC and dorsolateral prefrontal
cortex, are related to the persistence of the relapse-remit cycle in AUD (Durazzo et al.,
2011; Meyerhoff, Durazzo, & Ende, 2013; Paulus, 2007; Volkow, Wang, Tomasi, & Baler,
2013). It is noteworthy that Abstainers did not differ from Controls on any of the OFC,
DPFC subregions or left and right total frontal cortex volumes at AP2. Therefore, promoting
adaptive plasticity in components of the OFC, insula, dorsolateral prefrontal cortex, and/or
the total frontal cortex during early recovery, potentially through rTMS, other
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neurostimulation techniques (Bellamoli et al., 2014; Dunlop et al., 2017; Fettes et al., 2017),
and/or nutrition and exercise may decrease the risk of relapse in AUD.
This study has limitations that may affect the generalizability of the results. We observed no
statistically significant interactions for longitudinal analyses comparing Abstainers and
Relapsers over approximately 1 month of sobriety, despite simple effects tests
demonstrating different levels of volume recovery for Abstainers and Relapsers in multiple
regions. This may indicate we did not have sufficient power and/or within-group variance
was too high to yield statistically significant interactions. There is no universally accepted
definition of relapse in AUD (Witkiewitz & Marlatt, 2007); therefore, our operationalization
of relapse - any alcohol consumption within 12 months of initial assessment - may not be
congruent with criteria employed in other studies. Limitations also include the reliance on
self-report and/or medical records for the determination of drinking status at post-treatment
in most participants, and the inability to examine sex effects because of the small number of
females. It is imperative to include comparable number of females in future research to
investigate the potential influence of sex. Given both our previous volumetric work and
focus on common cortical rTMS targets in AUD, we confined our analyses to frontal and
insula volumes; however, it is possible that volume changes in other cortical or subcortical
regions are also associated with relapse in this sample.
In conclusion, the persistent regional and total frontal GM volume deficits observed over 4
weeks from last alcohol use in future Relapsers, combined with the volumetric findings from
previous cross-sectional studies, may define an neuroimaging endophenotype that
differentiates those who respond more favorably to typical psychosocial and
pharmacological interventions provided for AUD. Interventions that promote adaptive
neuroplasticity during early recovery in the cortical regions investigated in this study may
improve long-term outcomes in those seeking treatment for AUD.
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Figure 1.
Participant Assessment Timeline
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Figure 2.
Group Changes in Left Total Frontal Volume Over AP1 and AP2. Note. Group means and
error bars are offset for viewability.
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Figure 3.
Group Changes in Left Insula Volume Over AP1 and AP2. Note. Group means and error
bars are offset for viewability.
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Table 1.
Group Demographics and Clinical Variables
Measure Controls (n = 33) ABS (n = 39) REL (n = 65) Group comparisons*
Age (years) 46 (9) 53 (9) 51 (8) CON < ABS, REL
Education (years) 16.7 (2.6) 14.6 (2.2) 13.5 (1.9) CON > ABS, REL; ABS > REL
Males (%) 94 90 92
Caucasian (%) 73 79 74
Days abstinent at AP2 NA 33 (9) 33 (10)
Days until relapse NA NA 137 (80)
Lifetime average drinks/month 16 (14) 182 (93) 245 (145) CON < ABS, REL; ABS < REL
Anti-relapse/craving medication (%) NA 15 22
Antidepressant s (%) NA 5 12
Psychiatric comorbidity (%) NA 23 49 ABS < REL
Substance use disorder comorbidity (%) NA 21 15
Medical comorbidity (%) NA 44 54
Smokers (%) NA 51 62
FTND NA 5 (2) 5 (2)
Pack years NA 27 (19) 28 (21)
BDI 4 (3) 9 (8) 10 (8) CON < ABS, REL
STAI 33 (7) 47 (10) 50 (13) CON < ABS, REL
Body mass index 25 (5) 26 (5) 27 (5)
Number of previous AUD treatments (median) NA 2 3
Intracranial volume (cc) 1596 (162) 1599 (132) 1575 (148)
Note. ABS: Abstainers. AP2: Assessment point 2; BDI: Anti-relapse/craving medication: use of disulfiram, gabapentin and/or naltrexone; Beck
Depression Inventory. CON: Controls. FTND: Fagerstrom Test for Nicotine Dependence. NA: not applicable. REL: Relapsers. STAI: State -trait
Anxiety Inventory – Trait.
*
All listed group comparisons p < .05. Mean (SD).
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Table 3.
Longitudinal Volume Changes for Abstainers and Relapsers
Region Hemisphere and subregion Main Effects Simple Effects P-values Volume
Percent
Change AP1
to AP2
Group Main Effect Days
Abstinent
(Time)
Main Effect
ABS REL ABS REL
Anterior Cingulate
Left Caudal NS NS .10 NS 5.1 0.6
Right Caudal NS NS NS .018 3.9 1.7
Left Rostral F(1, 116) = 4.3, p = .
041
NS NS NS 0.7 0.2
Right Rostral .060 NS NS NS 4.5 1.5
Orbitofront al Left Medial NS F(1, 63) =
6.8, p = .012
.014 .004 2.2 3.4
Right Medial NS F(1, 63) =
5.5, p = .022
.060 NS 1.7 −0.3
Left Lateral F(1, 116) = 4.8, p = .
031
F(1, 64) =
21.2, p < .
001
NS <.001 0.0 0.9
Right Lateral .065 F(1, 64) =
10.7, p = .
002
.09 .01 0.7 0.5
Dorsal Prefrontal
Left Caudal Middle Frontal NS F(1, 63) =
9.6, p = .003
.041 .013 0.8 1.8
Right Caudal Middle Frontal NS NS NS NS 1.5 2.2
Left Rostral Middle Frontal .097 F(1, 63) =
7.8, p = .007
NS .017 0.9 2.2
Right Rostral Middle Frontal F(1, 115) = 5.9, p = .
017
F(1, 63) =
5.8, p = .019
NS .030 0.0 0.6
Left Superior Frontal .058 F(1, 64) =
4.4, p = .040
.017 NS 1.2 1.0
Right Superior Frontal F(1, 115) = 5.0, p = .
027
F(1, 64) =
4.9, p = .030
.037 NS 1.2 1.1
Precentral Left F(1, 115) = 5.9, p = .
017
F(1, 64) =
7.0, p = .010
NS .10 0.1 0.8
Right F(1, 115) = 8.7, p = .
004
.070 NS NS 0.0 0.6
Insula Left NS F(1, 64) =
18.9, p < .
001
NS <.001 0.6 2.4
Right NS F(1, 64) =
4.9, p < .031
NS .057 0.2 1.7
Total Frontal Cortical Left F(1, 115) = 6.0, p = .
015
F(1, 64) =
13.6, p < .
001
.028 .008 1.0 1.0
Right F(1, 115) = 6.8, p = .
010
F(1, 64) =
10.7, p = .
002
.049 .014 0.6 0.7
Note. Full statistics are provided for significant main effects (p < .05) and p-values only for statistical trends for main effects (i.e., p ≤.10); p-values
are provided for simple effects. P-values > .10 for any test listed as not significant (NS);
Brain Imaging Behav. Author manuscript.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Durazzo and Meyerhoff Page 22
ABS: Abstainers; REL: Relapsers.
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